Stephen J Atkinson (Stephen Atkinson)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

Journal of medicinal chemistry

Expert opinion on therapeutic patents

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, Sean Askin, Tony Cheung, Elisabetta Chiarparin, Muireann Coen, Iain T Collie, Ian L Dale, Claudia De Fusco, Keith Dillman, Laura Evans, Lyman J Feron, Alison J Foster, Michael Grondine, Vasudev Kantae, Gillian M Lamont, Scott Lamont, James T Lynch, Sten Nilsson Lill, Graeme R Robb, Jamal Saeh, Marianne Schimpl, James S Scott, James M Smith, Bharath Srinivasan, Sharon Tentarelli, Mercedes Vazquez-Chantada, David J Wagner, Jarrod J Walsh, David Watson, Beth Williamson
Development of a Series of Pyrrolopyridone MAT2A Inhibitors. Journal of medicinal chemistry 67 (6) (2024)
Stephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, Sean Askin, Tony Cheung, Elisabetta Chiarparin, Muireann Coen, Iain T Collie, Ian L Dale, Claudia De Fusco, Keith Dillman, Laura Evans, Lyman J Feron, Alison J Foster, Michael Grondine, Vasudev Kantae, Gillian M Lamont, Scott Lamont, James T Lynch, Sten Nilsson Lill, Graeme R Robb, Jamal Saeh, Marianne Schimpl, James S Scott, James M Smith, Bharath Srinivasan, Sharon Tentarelli, Mercedes Vazquez-Chantada, David J Wagner, Jarrod J Walsh, David Watson, Beth Williamson
Development of a Series of Pyrrolopyridone MAT2A Inhibitors. Journal of medicinal chemistry 67 (6) (2024)
Stephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, Sean Askin, Tony Cheung, Elisabetta Chiarparin, Muireann Coen, Iain T Collie, Ian L Dale, Claudia De Fusco, Keith Dillman, Laura Evans, Lyman J Feron, Alison J Foster, Michael Grondine, Vasudev Kantae, Gillian M Lamont, Scott Lamont, James T Lynch, Sten Nilsson Lill, Graeme R Robb, Jamal Saeh, Marianne Schimpl, James S Scott, James M Smith, Bharath Srinivasan, Sharon Tentarelli, Mercedes Vazquez-Chantada, David J Wagner, Jarrod J Walsh, David Watson, Beth Williamson
Development of a Series of Pyrrolopyridone MAT2A Inhibitors. Journal of medicinal chemistry (2024)
Stephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, Sean Askin, Tony Cheung, Elisabetta Chiarparin, Muireann Coen, Iain T Collie, Ian L Dale, Claudia De Fusco, Keith Dillman, Laura Evans, Lyman J Feron, Alison J Foster, Michael Grondine, Vasudev Kantae, Gillian M Lamont, Scott Lamont, James T Lynch, Sten Nilsson Lill, Graeme R Robb, Jamal Saeh, Marianne Schimpl, James S Scott, James M Smith, Bharath Srinivasan, Sharon Tentarelli, Mercedes Vazquez-Chantada, David J Wagner, Jarrod J Walsh, David Watson, Beth Williamson
Development of a Series of Pyrrolopyridone MAT2A Inhibitors. Journal of medicinal chemistry (2024)
Philip G Humphreys, Stephen J Atkinson, Paul Bamborough, Rino A Bit, Chun-Wa Chung, Peter D Craggs, Leanne Cutler, Rob Davis, Alan Ferrie, GangLi Gong, Laurie J Gordon, Matthew Gray, Lee A Harrison, Thomas G Hayhow, Andrea Haynes, Nick Henley, David J Hirst, Ian D Holyer, Matthew J Lindon, Cerys Lovatt, David Lugo, Scott McCleary, Judit Molnar, Qendresa Osmani, Chris Patten, Alex G S Preston, Inmaculada Rioja, Jonathan T Seal, Nicholas Smithers, Fenglai Sun, Dalin Tang, Simon Taylor, Natalie H Theodoulou, Clare Thomas, Robert J Watson, Christopher R Wellaway, Linrong Zhu, Nicholas C O Tomkinson, Rab K Prinjha
Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral Candidate. Journal of medicinal chemistry 65 (3) (2022)
Stephen J Atkinson, Laura Evans, James S Scott
A patent review of MAT2a inhibitors (2018-2021). Expert opinion on therapeutic patents 32 (10) (2022)
Simon C C Lucas, Stephen J Atkinson, Chun-Wa Chung, Rob Davis, Laurie Gordon, Paola Grandi, James J R Gray, Thomas Grimes, Alexander Phillipou, Alex G S Preston, Rab K Prinjha, Inmaculada Rioja, Simon Taylor, Nicholas C O Tomkinson, Ian Wall, Robert J Watson, James Woolven, Emmanuel H Demont
Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors. Journal of medicinal chemistry 64 (15) (2021)
Francesco Rianjongdee, Stephen J Atkinson, Chun-Wa Chung, Paola Grandi, James R J Gray, Laura J Kaushansky, Patricia Medeiros, Cassie Messenger, Alex Phillipou, Alex G S Preston, Rab K Prinjha, Inmaculada Rioja, Alexander Lee Satz, Simon Taylor, Ian D Wall, Robert J Watson, Gang Yao, Emmanuel H Demont
Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit. Journal of medicinal chemistry 64 (15) (2021)
Jonathan T Seal, Stephen J Atkinson, Paul Bamborough, Anna Bassil, Chun-Wa Chung, James Foley, Laurie Gordon, Paola Grandi, James R J Gray, Lee A Harrison, Ryan G Kruger, Jeanne J Matteo, Michael T McCabe, Cassie Messenger, Darren Mitchell, Alex Phillipou, Alex G S Preston, Rab K Prinjha, Francesco Rianjongdee, Inmaculada Rioja, Simon Taylor, Ian D Wall, Robert J Watson, James M Woolven, Anastasia Wyce, Xi-Ping Zhang, Emmanuel H Demont
Fragment-based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) Inhibitors. Journal of medicinal chemistry 64 (15) (2021)
Alex G S Preston, Stephen J Atkinson, Paul Bamborough, Chun-Wa Chung, Peter D Craggs, Laurie Gordon, Paola Grandi, James R J Gray, Emma J Jones, Matthew Lindon, Anne-Marie Michon, Darren J Mitchell, Rab K Prinjha, Francesco Rianjongdee, Inmaculada Rioja, Jonathan T Seal, Simon Taylor, Ian Wall, Robert J Watson, James Woolven, Emmanuel H Demont
Design and Synthesis of a Highly Selective and In Vivo-Capable Inhibitor of the Second Bromodomain of the Bromodomain and Extra Terminal Domain Family of Proteins. Journal of medicinal chemistry 63 (17) (2020)
Simon C C Lucas, Stephen J Atkinson, Paul Bamborough, Heather Barnett, Chun-Wa Chung, Laurie Gordon, Darren J Mitchell, Alexander Phillipou, Rab K Prinjha, Robert J Sheppard, Nicholas C O Tomkinson, Robert J Watson, Emmanuel H Demont
Optimization of Potent ATAD2 and CECR2 Bromodomain Inhibitors with an Atypical Binding Mode. Journal of medicinal chemistry 63 (10) (2020)
Jonathan T Seal, Stephen J Atkinson, Helen Aylott, Paul Bamborough, Chun-Wa Chung, Royston C B Copley, Laurie Gordon, Paola Grandi, James R J Gray, Lee A Harrison, Thomas G Hayhow, Matthew Lindon, Cassie Messenger, Anne-Marie Michon, Darren Mitchell, Alex G S Preston, Rab K Prinjha, Inmaculada Rioja, Simon Taylor, Ian D Wall, Robert J Watson, James M Woolven, Emmanuel H Demont
The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor. Journal of medicinal chemistry 63 (17) (2020)
Omer Gilan, Inmaculada Rioja, Kathy Knezevic, Matthew J Bell, Miriam M Yeung, Nicola R Harker, Enid Y N Lam, Chun-Wa Chung, Paul Bamborough, Massimo Petretich, Marjeta Urh, Stephen J Atkinson, Anna K Bassil, Emma J Roberts, Dane Vassiliadis, Marian L Burr, Alex G S Preston, Christopher R Wellaway, Thilo Werner, James R Gray, Anne-Marie Michon, Thomas Gobbetti, Vinod Kumar, Peter E Soden, Andrea Haynes, Johanna Vappiani, David F Tough, Simon J Taylor, Sarah-Jane Dawson, Marcus Bantscheff, Matthew Lindon, Gerard Drewes, Emmanuel H Demont, Danette L Daniels, Paola Grandi, Rabinder K Prinjha, Mark A Dawson
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation. Science (New York, N.Y.) 368 (6489) (2020)

Stephen J Atkinson.css-eqlu8i{font-size:small;padding-left:4px;} (Stephen Atkinson)

Publication Activity (10 Years)

Top Topics

Top Venues

Stephen J Atkinson (Stephen Atkinson)